Menu Menu


GSK Financials       Clear


GSK        0001131399    
Filing Date Form Type Description Document
2020-07-29 6-K SANOFI AND GSK AGREE UK DOSES OF COVID 19 VACCINE View Document
2020-07-28 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-07-24 6-K GSK RECEIVES POSITIVE CHMP OPINION FOR BELAMAF View Document
2020-07-22 SC 13D ACQUISITION OF BENEFICIAL OWNERSHIP View Document
2020-07-22 4 OWNERSHIP DOCUMENT View Document
2020-07-20 6-K GSK AND CUREVAC ENTER COLLABORATION View Document
2020-07-16 3 OWNERSHIP DOCUMENT View Document
2020-07-16 4 OWNERSHIP DOCUMENT View Document
2020-07-15 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-07-15 6-K FDA PANEL VOTES IN FAVOR OF BELANTAMAB MAFODOTIN View Document
2020-07-14 3/A OWNERSHIP DOCUMENT View Document
2020-07-14 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-07-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-07-10 SC 13D/A AMENDMENT TO FORM SC 13D View Document
2020-07-10 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-07-10 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-07-10 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-07-09 3 OWNERSHIP DOCUMENT View Document
2020-07-02 11-K View Document
2020-07-02 11-K View Document
2020-07-01 6-K TOTAL VOTING RIGHTS View Document
2020-06-29 SC 13D/A AMENDMENT TO FORM SC 13D View Document
2020-06-29 6-K GSK'S DAPRODUSTAT GAINS FIRST REGULATORY APPROVAL View Document
2020-06-22 4 OWNERSHIP DOCUMENT View Document
2020-06-22 SC 13D/A AMENDED SC13D View Document
2020-06-19 6-K FDA ADVISORY COMMITTEE REVIEW BELANTAMAB MAFODOTIN View Document
2020-06-18 6-K 6-K View Document
2020-06-18 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-06-17 6-K 6-K View Document
2020-06-17 SC 13D/A SC 13D/A View Document
2020-06-16 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-06-11 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-06-09 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-06-04 SC 13D/A AMENDMENT TO FORM SC 13D View Document
2020-06-01 6-K TOTAL VOTING RIGHTS View Document
2020-05-29 SD SD View Document
2020-05-26 SC 13D/A AMENDMENT TO FORM SC 13D View Document
2020-05-26 4 View Document
2020-05-26 6-K BLOCK LISTING INTERIM REVIEW View Document
2020-05-21 4 OWNERSHIP DOCUMENT View Document
2020-05-19 6-K HOLDING(S) IN COMPANY View Document
2020-05-18 6-K VIIV PREP JAB SHOWS HIGH EFFICACY OVER DAILY PILL View Document
2020-05-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-05-12 6-K 6-K View Document
2020-05-11 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-05-07 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-05-06 6-K RESULT OF AGM View Document
2020-05-04 SC 13G ACQUISITION OF BENEFICIAL OWNERSHIP View Document
2020-05-04 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-05-04 6-K PUBLICATION OF A PROSPECTUS View Document
2020-05-04 6-K RIGHTS ATTACHED TO ORDINARY SHARES View Document
2020-05-01 6-K TOTAL VOTING RIGHTS View Document
2020-04-30 6-K GSK'S ZEJULA APPROVED IN FIRST-LINE OVARIAN CANCER View Document
2020-04-29 6-K 1ST QUARTER RESULTS View Document
2020-04-29 6-K ARRANGEMENTS FOR SHAREHOLDER WEBCAST View Document
2020-04-16 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-04-16 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-04-16 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-04-14 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-04-14 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-04-14 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-04-14 6-K SANOFI AND GSK COLLABORATION TO FIGHT COVID-19 View Document
2020-04-09 6-K AGM - CHANGE OF ARRANGEMENTS View Document
2020-04-06 6-K GSK AND VIR BIOTECHNOLOGY ENTER COLLABORATION View Document
2020-04-01 6-K GSK COMPLETES DIVESTMENT OF HORLICKS View Document
2020-04-01 6-K TOTAL VOTING RIGHTS View Document
2020-03-30 6-K CONSUMER HEALTHCARE PRODUCT SALES CATEGORY CHANGES View Document
2020-03-24 6-K PUBLICATION OF AGM NOTICE View Document
2020-03-20 6-K DIRECTORATE CHANGE View Document
2020-03-18 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-03-13 6-K EMTN PROSPECTUS SUPPLEMENT UPDATE View Document
2020-03-11 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-03-09 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-03-09 6-K PUBLICATION OF GSK 2019 FORM 20-F View Document
2020-03-06 IRANNOTICE IRANNOTICE View Document
2020-03-06 20-F 20-F View Document
2020-03-04 6-K ANNUAL FINANCIAL REPORT View Document
2020-03-02 6-K TOTAL VOTING RIGHTS View Document
2020-02-28 SC 13G/A AMENDMENT NO. 2 TO FORM SC 13G View Document
2020-02-27 SC 13D/A AMENDMENT TO FORM SC 13D View Document
2020-02-21 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-02-20 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-02-20 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-02-20 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-02-19 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-02-19 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-02-19 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-02-19 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-02-19 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2020-02-18 SC 13D/A AMENDMENT NO. 4 TO SC 13D View Document
2020-02-18 SC 13D/A AMENDMENT NO. 2 TO FORM SC 13D View Document
2020-02-14 SC 13G/A AMENDMENT TO FORM SC 13G View Document
2020-02-14 SC 13D/A AMENDMENT TO FORM SC 13D View Document
2020-02-14 SC 13D/A AMENDMENT TO FORM SC 13D View Document
2020-02-14 SC 13D/A AMENDMENT TO FORM SC 13D View Document
2020-02-14 SC 13G/A AMENDMENT TO FORM SC 13G View Document
2020-02-14 SC 13G SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP View Document
2020-02-14 SC 13D/A AMENDMENT TO FORM SC 13D View Document
2020-02-14 SC 13D/A AMENDMENT TO FORM SC 13D View Document
2020-02-14 SC 13D/A AMENDMENT TO FORM SC 13D View Document

Find registration statements, periodic reports, and other forms by typing ticker symbol of a company.

Ticker:

Search company filings and access detailed reports including 10-K, 10-Q, 8-K, and other critical filings. Stay informed on corporate disclosures, regulatory filings, and updates with our easy-to-use EDGAR API filings search tool.



We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas